Availability of data and material
Data are available on request from the authors.
References
Robinson KN, Terrazas S, Giordano-Mooga S, Xavier NA (2020) The role of heteroplasmy in the diagnosis and management of maternally inherited diabetes and deafness. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 26:241–246. https://doi.org/10.4158/EP-2019-0270
Zhu J, Yang P, Liu X et al (2017) The clinical characteristics of patients with mitochondrial tRNA Leu(UUR)m.3243A > G mutation: compared with type 1 diabetes and early onset type 2 diabetes. J Diabetes Complicat 31:1354–1359. https://doi.org/10.1016/j.jdiacomp.2017.04.001
Naing A, Kenchaiah M, Krishnan B, et al. (2014) Maternally inherited diabetes and deafness (MIDD): diagnosis and management. J Diabetes Complicat 28:542–546. https://doi.org/10.1016/j.jdiacomp.2014.03.006
Ganda OP, Plutzky J, Sanganalmath SK, et al. (2018) Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials. Diabetes Obes Metab 20:2389–2398. https://doi.org/10.1111/dom.13384
Leiter LA, Cariou B, Müller-Wieland D, et al. (2017) Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: the ODYSSEY DM-INSULIN randomized trial. Diabetes Obes Metab 19:1781–1792. https://doi.org/10.1111/dom.13114
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to the topical collection Pregnancy and Diabetes, managed by Antonio Secchi and Marina Scavini.
Rights and permissions
About this article
Cite this article
Schultes, B., Ernst, B. & Schmid, S.M. Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab. Acta Diabetol 58, 1575–1577 (2021). https://doi.org/10.1007/s00592-021-01776-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-021-01776-w